Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.4M Sell
93,841
-20,703
-18% -$7.09M 0.39% 59
2026
Q1
$40.6M Buy
114,544
+9,094
+9% +$3.24M 0.51% 43
2025
Q4
$34.6M Buy
105,450
+9,974
+10% +$3.16M 0.43% 50
2025
Q3
$27M Sell
95,476
-255
-0.3% -$74K 0.34% 63
2025
Q2
$26.7M Buy
95,731
+11,888
+14% +$3.37M 0.37% 60
2025
Q1
$26.1M Buy
83,843
+28,064
+50% +$8.29M 0.38% 63
2024
Q4
$14.5M Buy
55,779
+3,047
+6% +$904K 0.2% 113
2024
Q3
$17M Sell
52,732
-1,750
-3% -$572K 0.24% 103
2024
Q2
$17M Buy
54,482
+2,650
+5% +$779K 0.26% 93
2024
Q1
$14.7M Buy
51,832
+1,807
+4% +$529K 0.23% 107
2023
Q4
$14.4M Buy
50,025
+275
+0.6% +$74.9K 0.25% 96
2023
Q3
$13.4M Sell
49,750
-2,242
-4% -$560K 0.26% 94
2023
Q2
$11.5M Buy
51,992
+11,076
+27% +$2.57M 0.21% 110
2023
Q1
$9.89M Buy
40,916
+3,827
+10% +$939K 0.19% 129
2022
Q4
$9.74M Sell
37,089
-5,632
-13% -$1.51M 0.2% 126
2022
Q3
$9.63M Buy
42,721
+752
+2% +$182K 0.21% 117
2022
Q2
$10.2M Sell
41,969
-1,128
-3% -$276K 0.21% 113
2022
Q1
$10.4M Sell
43,097
-1,271
-3% -$292K 0.17% 132
2021
Q4
$9.98M Buy
44,368
+2,611
+6% +$551K 0.15% 147
2021
Q3
$8.88M Buy
41,757
+1,491
+4% +$343K 0.14% 159
2021
Q2
$9.81M Sell
40,266
-4,997
-11% -$1.23M 0.15% 151
2021
Q1
$11.3M Buy
45,263
+4,478
+11% +$1.07M 0.18% 122
2020
Q4
$9.38M Buy
40,785
+4,845
+13% +$1.12M 0.17% 130
2020
Q3
$9.13M Sell
35,940
-57
-0.2% -$14.1K 0.18% 125
2020
Q2
$8.49M Buy
35,997
+1,007
+3% +$230K 0.18% 127
2020
Q1
$7.09M Sell
34,990
-3,082
-8% -$673K 0.19% 124
2019
Q4
$9.18M Buy
38,072
+9,442
+33% +$2.08M 0.19% 119
2019
Q3
$5.54M Sell
28,630
-9,262
-24% -$1.78M 0.12% 190
2019
Q2
$6.98M Buy
37,892
+3,740
+11% +$670K 0.16% 145
2019
Q1
$6.49M Buy
34,152
+3,166
+10% +$605K 0.15% 147
2018
Q4
$6.03M Buy
30,986
+5,672
+22% +$1.11M 0.17% 131
2018
Q3
$5.25M Buy
25,314
+236
+0.9% +$46.5K 0.13% 186
2018
Q2
$4.63M Sell
25,078
-85
-0.3% -$15K 0.14% 184
2018
Q1
$4.29M Sell
25,163
-3,352
-12% -$615K 0.16% 161
2017
Q4
$4.96M Buy
28,515
+2,876
+11% +$509K 0.19% 139
2017
Q3
$4.78M Buy
25,639
+3,529
+16% +$625K 0.17% 128
2017
Q2
$3.81M Buy
22,110
+3,157
+17% +$513K 0.13% 176
2017
Q1
$3.11M Buy
18,953
+667
+4% +$111K 0.11% 203
2016
Q4
$2.67M Sell
18,286
-6,780
-27% -$1.02M 0.11% 214
2016
Q3
$4.18M Buy
25,066
+503
+2% +$85.1K 0.18% 119
2016
Q2
$3.74M Buy
24,563
+8,480
+53% +$1.32M 0.17% 130
2016
Q1
$2.41M Buy
16,083
+1,458
+10% +$217K 0.12% 184
2015
Q4
$2.37M Buy
14,625
+88
+0.6% +$13.8K 0.12% 183
2015
Q3
$2.01M Buy
14,537
+646
+5% +$102K 0.1% 213
2015
Q2
$2.13M Buy
13,891
+82
+0.6% +$13.1K 0.1% 237
2015
Q1
$2.21M Sell
13,809
-728
-5% -$115K 0.1% 228
2014
Q4
$2.32M Sell
14,537
-145
-1% -$22.6K 0.11% 201
2014
Q3
$2.06M Buy
14,682
+561
+4% +$73.2K 0.1% 214
2014
Q2
$1.67M Buy
14,121
+304
+2% +$35.2K 0.08% 245
2014
Q1
$1.7M Sell
13,817
-4,954
-26% -$601K 0.09% 235
2013
Q4
$2.14M Buy
18,771
+15
+0.1% +$1.71K 0.11% 200
2013
Q3
$2.1M Buy
18,756
+2,166
+13% +$235K 0.11% 188
2013
Q2
$1.64M Buy
+16,590
New +$1.72M 0.09% 199

Other funds holding AMGN

Stephens Inc's AMGN Position: Q2 2026 in Review

Stephens Inc reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $7.09M and leaving 93,841 shares worth $34.4M. The position accounts for 0.39% of the portfolio, ranked #59.

Stephens Inc first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $40.6M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Stephens Inc held 93,841 shares of Amgen worth $34.4M as of Q2 2026.
  • Stephens Inc sold 20,703 Amgen shares in Q2 2026, an estimated $7.09M.
  • Amgen made up 0.39% of Stephens Inc's portfolio in Q2 2026, its #59 holding.
  • Stephens Inc first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Stephens Inc's Amgen position peaked at $40.6M in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.